Janssen signs first two data centres to its Haematology Outcomes Network in Europe (HONEUR)

On Apr 12, 19, 10:04 AM

Improving results for patients by realising the transformational potential of Real World Data BEERSE, BELGIUM, 11 April 2019 - The Janssen Pharmaceutical Companies of Johnson & Johnson have...

Virtual EHA 2020 Abstract: "Patient Similarity Analysis and Visualisation in Multiple Myeloma"

On Sep 2, 20, 12:34 PM

HONEUR’s new Interactive Patient Similarity Analysis and Visualisation Tool was accepted and published at EHA’s (European Haematology Association) 25th annual congress in June 2020. As every...

6 more data partners have joined the Haematology Outcomes Network In Europe (HONEUR)

On Feb 28, 20, 2:35 PM

We're delighted to welcome six more data partners to join the HONEUR collaborative network of he Janssen Pharmaceutical Companies of Johnson & Johnson. HONEUR (Haematology Outcomes Network in...

EHA 2019 Abstract: "Distributed statistics in a Federated Model to Support Real World Data Research in Hematology"

On Sep 8, 20, 9:58 AM

Objective: enabling the use of distributed statistics across federated data models

News - News Events Publications filters

On Sep 14, 18, 6:07 AM

News

Copy approval code CP-180162

On Feb 4, 19, 7:24 PM

CP-73766

Home - What is HONEUR

On Aug 3, 20, 8:41 AM

What is HONEUR? Treating patients with haematological malignancies has progressed significantly in recent years, but extensive scientific research is still needed. Fortunately, there’s a huge...

Home - Our Mission and vision

On Sep 3, 20, 9:52 AM

Our mission With HONEUR, we have created a secure, collaborative platform that enables partnering data centres across Europe, including Janssen, to liberate the transformational potential of...